Tiago Lopes: Can AI Predict Immune Reactions of New Drugs?
Tiago Lopes, Research Scientist at Heidelberg University, shared on LinkedIn:
”Can AI predict immune reactions of new drugs? Yes.
Its not perfect, but it is very good.
In this paper fresh from the oven, my colleagues from Japan and I present a new coagulation factor 8 (FVIII), designed and tested as a gene therapy.
People who have a defect in this gene live with hemophilia, a coagulation problem that requires constant injections; and even then, they are at constant risk of joint, muscle and other hemorrhages.
The treatment is super expensive, and still has a major problem of triggering an immune reaction; it renders the treatment ineffective, which without a doubt, sucks.
Here, a comprehensive and reliable AI prediction was made, showing this FVIII variant is not worse than the “original” protein that people have.
Hope. This is the word for patients and their families.
We are working around the clock to have your kids playing soccer without worrying about not walking the next day.”

Stay updated with Hemostasis Today.
-
Nov 14, 2026, 00:04Carlos A. Metidieri Menegozzo: The First Priority in Trauma Transfusion May Be Time to First Blood Product
-
Nov 13, 2026, 23:43Alamgir Hosen Ronit: Corrected Platelet Count in EDTA Induced Platelet Aggregation
-
Nov 13, 2026, 23:32Evi Loos: Can PRP Improve Pain in Thumb Base Osteoarthritis?
-
Nov 13, 2026, 23:10Cesar de Almeida Neto: Digital Connectivity Can Transform Plateletpheresis Practice
-
Nov 13, 2026, 23:10Chien-Wen Liew: Where PRP Actually Sits in the Evidence
-
Nov 13, 2026, 23:08Erika Koppers: Continuing the Collaborative Journey Towards Equitable Haemophilia Care in South Africa
-
Nov 13, 2026, 23:06Büşra Ece Günaydın: A New Approach to Factor VIII Gene Insertion for Hemophilia A
-
Nov 13, 2026, 22:57Rolf Bekendam: Moderating a Conversation With Experts on Rare Bleeding Disorders
-
Nov 13, 2026, 16:17Shailendra Singh: Bombay Hospital Jaipur Inaugurates New Facility with Voluntary Blood Donation Camp